Copyright Reports & Markets. All rights reserved.

Global Parenteral Drugs Glass Packaging Market Growth 2021-2026

Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Parenteral Drugs Glass Packaging Consumption 2016-2026
    • 2.1.2 Parenteral Drugs Glass Packaging Consumption CAGR by Region
  • 2.2 Parenteral Drugs Glass Packaging Segment by Type
    • 2.2.1 Polyvinyl Chloride (PVC)
    • 2.2.2 Polyolefin
  • 2.3 Parenteral Drugs Glass Packaging Sales by Type
    • 2.3.1 Global Parenteral Drugs Glass Packaging Sales Market Share by Type (2016-2021)
    • 2.3.2 Global Parenteral Drugs Glass Packaging Revenue and Market Share by Type (2016-2021)
    • 2.3.3 Global Parenteral Drugs Glass Packaging Sale Price by Type (2016-2021)
  • 2.4 Parenteral Drugs Glass Packaging Segment by Application
    • 2.4.1 Large Volume Parenteral (LVP)
    • 2.4.2 Small Volume Parenteral (SVP)
  • 2.5 Parenteral Drugs Glass Packaging Sales by Application
    • 2.5.1 Global Parenteral Drugs Glass Packaging Sale Market Share by Application (2016-2021)
    • 2.5.2 Global Parenteral Drugs Glass Packaging Revenue and Market Share by Application (2016-2021)
    • 2.5.3 Global Parenteral Drugs Glass Packaging Sale Price by Application (2016-2021)

3 Global Parenteral Drugs Glass Packaging by Company

  • 3.1 Global Parenteral Drugs Glass Packaging Sales Market Share by Company
    • 3.1.1 Global Parenteral Drugs Glass Packaging Sales by Company (2019-2021)
    • 3.1.2 Global Parenteral Drugs Glass Packaging Sales Market Share by Company (2019-2021)
  • 3.2 Global Parenteral Drugs Glass Packaging Revenue Market Share by Company
    • 3.2.1 Global Parenteral Drugs Glass Packaging Revenue by Company (2019-2021)
    • 3.2.2 Global Parenteral Drugs Glass Packaging Revenue Market Share by Company (2019-2021)
  • 3.3 Global Parenteral Drugs Glass Packaging Sale Price by Company
  • 3.4 Global Manufacturers Parenteral Drugs Glass Packaging Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Parenteral Drugs Glass Packaging Product Location Distribution
    • 3.4.2 Players Parenteral Drugs Glass Packaging Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 Parenteral Drugs Glass Packaging by Region

  • 4.1 Global Parenteral Drugs Glass Packaging by Region
    • 4.1.1 Global Parenteral Drugs Glass Packaging Sales by Region
    • 4.1.2 Global Parenteral Drugs Glass Packaging Revenue by Region
  • 4.2 Americas Parenteral Drugs Glass Packaging Sales Growth
  • 4.3 APAC Parenteral Drugs Glass Packaging Sales Growth
  • 4.4 Europe Parenteral Drugs Glass Packaging Sales Growth
  • 4.5 Middle East & Africa Parenteral Drugs Glass Packaging Sales Growth

5 Americas

  • 5.1 Americas Parenteral Drugs Glass Packaging Sales by Country
    • 5.1.1 Americas Parenteral Drugs Glass Packaging Sales by Country (2016-2021)
    • 5.1.2 Americas Parenteral Drugs Glass Packaging Revenue by Country (2016-2021)
  • 5.2 Americas Parenteral Drugs Glass Packaging Sales by Type
  • 5.3 Americas Parenteral Drugs Glass Packaging Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Parenteral Drugs Glass Packaging Sales by Region
    • 6.1.1 APAC Parenteral Drugs Glass Packaging Sales by Region (2016-2021)
    • 6.1.2 APAC Parenteral Drugs Glass Packaging Revenue by Region (2016-2021)
  • 6.2 APAC Parenteral Drugs Glass Packaging Sales by Type
  • 6.3 APAC Parenteral Drugs Glass Packaging Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Parenteral Drugs Glass Packaging by Country
    • 7.1.1 Europe Parenteral Drugs Glass Packaging Sales by Country (2016-2021)
    • 7.1.2 Europe Parenteral Drugs Glass Packaging Revenue by Country (2016-2021)
  • 7.2 Europe Parenteral Drugs Glass Packaging Sales by Type
  • 7.3 Europe Parenteral Drugs Glass Packaging Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Parenteral Drugs Glass Packaging by Country
    • 8.1.1 Middle East & Africa Parenteral Drugs Glass Packaging Sales by Country (2016-2021)
    • 8.1.2 Middle East & Africa Parenteral Drugs Glass Packaging Revenue by Country (2016-2021)
  • 8.2 Middle East & Africa Parenteral Drugs Glass Packaging Sales by Type
  • 8.3 Middle East & Africa Parenteral Drugs Glass Packaging Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Country

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers and Impact
    • 9.1.1 Growing Demand from Key Regions
    • 9.1.2 Growing Demand from Key Applications and Potential Industries
  • 9.2 Market Challenges and Impact
  • 9.3 Market Trends

10 Marketing, Distributors and Customer

  • 10.1 Sales Channel
    • 10.1.1 Direct Channels
    • 10.1.2 Indirect Channels
  • 10.2 Parenteral Drugs Glass Packaging Distributors
  • 10.3 Parenteral Drugs Glass Packaging Customer

11 Global Parenteral Drugs Glass Packaging Market Forecast

  • 11.1 Global Parenteral Drugs Glass Packaging Forecast by Region
    • 11.1.1 Global Parenteral Drugs Glass Packaging Forecast by Regions (2021-2026)
    • 11.2.2 Global Parenteral Drugs Glass Packaging Revenue Forecast by Regions (2021-2026)
  • 11.2 Americas Forecast by Country
  • 11.3 APAC Forecast by Region
  • 11.4 Europe Forecast by Country
  • 11.5 Middle East & Africa Forecast by Country
  • 11.6 Global Parenteral Drugs Glass Packaging Forecast by Type
  • 11.7 Global Parenteral Drugs Glass Packaging Forecast by Application

12 Key Players Analysis

  • 12.1 Ypsomed Holding AG
    • 12.1.1 Ypsomed Holding AG Company Information
    • 12.1.2 Ypsomed Holding AG Parenteral Drugs Glass Packaging Product Offered
    • 12.1.3 Ypsomed Holding AG Parenteral Drugs Glass Packaging Sales, Revenue, Price and Gross Margin (2019-2021)
    • 12.1.4 Ypsomed Holding AG Main Business Overview
    • 12.1.5 Ypsomed Holding AG Latest Developments
  • 12.2 Gerresheimer AG
    • 12.2.1 Gerresheimer AG Company Information
    • 12.2.2 Gerresheimer AG Parenteral Drugs Glass Packaging Product Offered
    • 12.2.3 Gerresheimer AG Parenteral Drugs Glass Packaging Sales, Revenue, Price and Gross Margin (2019-2021)
    • 12.2.4 Gerresheimer AG Main Business Overview
    • 12.2.5 Gerresheimer AG Latest Developments
  • 12.3 SiO2 Medical Products
    • 12.3.1 SiO2 Medical Products Company Information
    • 12.3.2 SiO2 Medical Products Parenteral Drugs Glass Packaging Product Offered
    • 12.3.3 SiO2 Medical Products Parenteral Drugs Glass Packaging Sales, Revenue, Price and Gross Margin (2019-2021)
    • 12.3.4 SiO2 Medical Products Main Business Overview
    • 12.3.5 SiO2 Medical Products Latest Developments
  • 12.4 Schott AG
    • 12.4.1 Schott AG Company Information
    • 12.4.2 Schott AG Parenteral Drugs Glass Packaging Product Offered
    • 12.4.3 Schott AG Parenteral Drugs Glass Packaging Sales, Revenue, Price and Gross Margin (2019-2021)
    • 12.4.4 Schott AG Main Business Overview
    • 12.4.5 Schott AG Latest Developments
  • 12.5 Ompi Stevanato Group
    • 12.5.1 Ompi Stevanato Group Company Information
    • 12.5.2 Ompi Stevanato Group Parenteral Drugs Glass Packaging Product Offered
    • 12.5.3 Ompi Stevanato Group Parenteral Drugs Glass Packaging Sales, Revenue, Price and Gross Margin (2019-2021)
    • 12.5.4 Ompi Stevanato Group Main Business Overview
    • 12.5.5 Ompi Stevanato Group Latest Developments
  • 12.6 Becton Dickinson and Company
    • 12.6.1 Becton Dickinson and Company Company Information
    • 12.6.2 Becton Dickinson and Company Parenteral Drugs Glass Packaging Product Offered
    • 12.6.3 Becton Dickinson and Company Parenteral Drugs Glass Packaging Sales, Revenue, Price and Gross Margin (2019-2021)
    • 12.6.4 Becton Dickinson and Company Main Business Overview
    • 12.6.5 Becton Dickinson and Company Latest Developments
  • 12.7 MeadWestvaco Corporation
    • 12.7.1 MeadWestvaco Corporation Company Information
    • 12.7.2 MeadWestvaco Corporation Parenteral Drugs Glass Packaging Product Offered
    • 12.7.3 MeadWestvaco Corporation Parenteral Drugs Glass Packaging Sales, Revenue, Price and Gross Margin (2019-2021)
    • 12.7.4 MeadWestvaco Corporation Main Business Overview
    • 12.7.5 MeadWestvaco Corporation Latest Developments
  • 12.8 Unilife Corporation Inc
    • 12.8.1 Unilife Corporation Inc Company Information
    • 12.8.2 Unilife Corporation Inc Parenteral Drugs Glass Packaging Product Offered
    • 12.8.3 Unilife Corporation Inc Parenteral Drugs Glass Packaging Sales, Revenue, Price and Gross Margin (2019-2021)
    • 12.8.4 Unilife Corporation Inc Main Business Overview
    • 12.8.5 Unilife Corporation Inc Latest Developments
  • 12.9 West Pharmaceutical Services
    • 12.9.1 West Pharmaceutical Services Company Information
    • 12.9.2 West Pharmaceutical Services Parenteral Drugs Glass Packaging Product Offered
    • 12.9.3 West Pharmaceutical Services Parenteral Drugs Glass Packaging Sales, Revenue, Price and Gross Margin (2019-2021)
    • 12.9.4 West Pharmaceutical Services Main Business Overview
    • 12.9.5 West Pharmaceutical Services Latest Developments
  • 12.10 Terumo Corporation
    • 12.10.1 Terumo Corporation Company Information
    • 12.10.2 Terumo Corporation Parenteral Drugs Glass Packaging Product Offered

According to this latest study, the 2021 growth of Parenteral Drugs Glass Packaging will have significant change from previous year. By the most conservative estimates of global Parenteral Drugs Glass Packaging market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Parenteral Drugs Glass Packaging market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Parenteral Drugs Glass Packaging market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Polyvinyl Chloride (PVC)
Polyolefin

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Large Volume Parenteral (LVP)
Small Volume Parenteral (SVP)

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Ypsomed Holding AG
Gerresheimer AG
SiO2 Medical Products
Schott AG
Ompi Stevanato Group
Becton Dickinson and Company
MeadWestvaco Corporation
Unilife Corporation Inc
West Pharmaceutical Services
Terumo Corporation
Berry Plastics Corporation
Owens-Illinois
RPC Group
Graphic Packaging Group

Buy now